RISK-FACTORS FAR INTRACRANIAL HEMORRHAGE IN OUTPATIENTS TAKING WARFARIN

被引:729
|
作者
HYLEK, EM
SINGER, DE
机构
[1] Massachusetts General Hospital, Boston, MA
[2] General Internal Medicine Unit, Massachusetts General Hospital, Boston, MA 02114
关键词
D O I
10.7326/0003-4819-120-11-199406010-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To explore the rational use of anticoagulants, especially among the elderly, balancing antithrombotic efficacy and risk for hemorrhage. Previous prospective studies have not provided powerful assessments of risk factors for intracranial hemorrhage, the dominant complication in reversing the anticoagulant decision. Design: Case-control analysis. Setting: A large general hospital and its anticoagulant therapy unit. Patients: 121 consecutive adult patients taking warfarin who were hospitalized with intracranial hemorrhage were each matched to three contemporaneous controls randomly selected from among outpatients managed by our hospital anticoagulant therapy unit. Results: 77 patients had intracerebral hemorrhage (46% fatal) and 44 had subdural hemorrhage (20% fatal). The prothrombin time ratio (PTR) was the dominant risk factor for intracranial hemorrhage. For each 0.5 increase in PTR over the entire range, the risk for intracerebral hemorrhage doubled (odds ratio, 2.1; 95% CI, 1.4 to 2.9). For subdural hemorrhage, the risk was unchanged over the PTR range from 1.0 to 2.0 but rose dramatically above a PTR of 2.0 (approximate international normalized ratio, 4.0). Age was the only other significant independent risk factor for subdural hemorrhage (odds ratio, 2.0 per decade; CI, 1.3 to 3.1). For intracerebral hemorrhage, age was of borderline significance (odds ratio, 1.3 per decade; CI, 1.0 to 1.6) after controlling for PTR and the two other independent risk factors: history of cerebrovascular disease (odds ratio, 3.1; CI, 1.7 to 5.6) and presence of a prosthetic heart valve (odds ratio, 2.8; CI, 1.3 to 5.8). Conclusions: The results emphasize the importance of maintaining the prothrombin time ratios under 2.0 and the need for especially careful use of warfarin in the elderly.
引用
收藏
页码:897 / 902
页数:6
相关论文
共 50 条
  • [41] ANTENATAL RISK-FACTORS FOR GERMINAL MATRIX HEMORRHAGE AND INTRAVENTRICULAR HEMORRHAGE IN PRETERM INFANTS
    SPINILLO, A
    OMETTO, A
    BOTTINO, R
    PIAZZI, G
    IASCI, A
    RONDINI, G
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1995, 60 (01) : 13 - 19
  • [42] Intracranial Hemorrhage on Warfarin: Time to Reversal Is of the Essence
    Mehta, Chandan
    Jones, Mathew
    Cuero, Mauricio Ruiz
    Wellwood, Jody
    Rehman, Mohammed
    Mitsias, Panayiotis
    Varelas, Panayiotis
    NEUROLOGY, 2016, 86
  • [43] Antiplatelet agents, warfarin, and epidemic intracranial hemorrhage
    Siracuse, Jeffrey J.
    Robich, Michael P.
    Gautam, Shiva
    Kasper, Ekkehard M.
    Moorman, Donald W.
    Hauser, Carl J.
    SURGERY, 2010, 148 (04) : 724 - 729
  • [44] ACQUIRED RISK-FACTORS FOR DEEP-VEIN THROMBOSIS IN SYMPTOMATIC OUTPATIENTS
    COGO, A
    BERNARDI, E
    PRANDONI, P
    GIROLAMI, B
    NOVENTA, F
    SIMIONI, P
    GIROLAMI, A
    ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (02) : 164 - 168
  • [45] Risk factors for dural arteriovenous fistula intracranial hemorrhage
    Peng, Tangming
    Liu, Aihua
    Jia, Jianwen
    Jiang, Chuhan
    Li, Youxiang
    Wu, Zhongxue
    Yang, Xinjian
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (05) : 769 - 772
  • [46] Risk factors for intracranial hemorrhage in adults with acute leukemia
    Maze, Dawn
    Al-Abri, Mahmood
    Farooq, Khadija
    Atenafu, Eshetu G.
    Nixon, Shannon
    Lieberman, Lani
    TRANSFUSION, 2021, 61 (12) : 3303 - 3308
  • [47] Intracranial hemorrhage in glioblastoma: Incidence, risk factors, and outcome
    Lee, Seok-Yun
    Devos, Patrick
    Bink, Andrea
    Regli, Luca
    Weller, Michael
    Le Rhun, Emilie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] RISK-FACTORS FOR HYPO-KALMIA AND HYPERKALEMIA IN DIURETIC TREATED OUTPATIENTS
    TIERNEY, W
    MCDONALD, C
    CLINICAL RESEARCH, 1982, 30 (04): : A728 - A728
  • [49] Should Warfarin Be Restarted After Warfarin-Associated Intracranial Hemorrhage?
    Coppens, Michiel
    Eikelboom, John W.
    Weitz, Jeffrey I.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (01) : 6 - 8
  • [50] RISK-FACTORS FAR THE DEVELOPMENT OF GALL-BLADDER DISEASE
    RHODES, M
    GUT, 1994, 35 (08) : 1152 - 1152